Los Angeles Capital Management LLC Sells 297 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Los Angeles Capital Management LLC reduced its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 2.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,414 shares of the company’s stock after selling 297 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.06% of Addus HomeCare worth $1,431,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quarry LP bought a new position in Addus HomeCare in the 3rd quarter worth $28,000. Farther Finance Advisors LLC grew its position in shares of Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares during the period. KBC Group NV grew its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the last quarter. Assetmark Inc. grew its position in Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in Addus HomeCare by 34.5% during the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock valued at $158,000 after purchasing an additional 323 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Down 1.0 %

NASDAQ ADUS opened at $95.77 on Friday. Addus HomeCare Co. has a 12 month low of $87.88 and a 12 month high of $136.72. The company’s 50 day moving average is $122.60 and its two-hundred day moving average is $126.08. The stock has a market cap of $1.74 billion, a price-to-earnings ratio of 21.92, a PEG ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Sell-side analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Stephens lowered their target price on shares of Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating on the stock in a research note on Wednesday. JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reiterated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday. Finally, StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.